Cronos Group Inc.: Cronos Group Reports 2023 First Quarter Results

Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022; on a constant

Related Keywords

Ukraine ,Canada ,Israel ,Russia ,Toronto ,Ontario ,United States ,Canadian ,Israeli ,Mike Gorenstein ,Cronos Growco ,Shayne Laidlaw ,Drug Administration ,Ontario Securities Commission Settlement Agreement ,Ginkgo Bioworks Holdings Inc ,Company The Altria Investment ,Cronos Growing Company Inc ,Altria Group Inc ,Us Federal Trade Commission ,Nasdaq ,Bloomberg ,Trademark Office ,Cronos Group ,Us Department Of Agriculture ,Us Drug Enforcement Administration ,Cronos Group Inc ,Pharmacann Option In Inc ,Israeli Shekel ,Kiwi Haze ,Deep Dreamz ,Sonic Lemon Fuel ,Growing Company ,Forward Looking Statements ,Looking Statements ,Peace Naturals Campus ,Ginkgo Bioworks Holdings ,Enforcement Administration ,Trade Commission ,Altria Group ,Ontario Securities Commission ,Settlement Order ,Settlement Agreement ,Securities Act ,Pharmacann Option ,Altria Investment ,Annual Report ,Improvement Act ,Consolidated Statements ,Net Loss ,Generally Accepted Accounting Principles ,Months Ended March ,Peace Naturals ,Israeli New Shekels ,Gefallene Big Techs ,Cronos ,Group ,Reports ,023 ,First ,Quarter ,Results ,